起订量:
ACTICLOT® dPT™ Dilute Time Test
免费会员
代理商北京科瑞美科技有限公司是一家专门从事临床实验室诊断产品销售及售后服务的企业。经过几年的不懈努力,得到广大用户的肯定与支持。
科瑞美公司以引进“新产品、新技术”为己任,目前已拥有四十多家国外品牌,产品涉及重组蛋白、抗体、细胞因子、骨代谢、传染病、肿瘤、激素、心肌标志物、糖尿病、自身免疫、蛋白质芯片、优生优育等众多领域。相当多的产品和相关技术在国内的推广与国外几乎是同步的,为广大的科研工作者提供了有力的支持。
多年来我们不断推陈出新,积极倡导“锐意进取、精益求精、信守承诺、探索求新”的企业精神,以“保证质量,提高客户满意度”为经营宗旨,以质量求生存,以品种求发展,以科学技术为先导,致力于中国检验领域的缜密科学。面对未来,我们将一如既往的提供高质量的产品、优惠的价格及优质的服务。并秉持“专业、真诚”的服务宗旨,期待着与您在更为广阔的天地里,成就共同发展,共创双赢的目标!期待着与您的合作!
ACTICLOT® dPT™ Dilute Time Test Clinical studies show that a dilute prothrombin time test is an effective LA coagulation assay and can identify LA that are not detected by other tests such as a lupus-sensitive APTT and a dilute Russell’s Viper Venom test.
ACTICLOT® dPT™ Dilute Time Test ACTICLOT dPT is a fully integrated dilute prothrombin time test for screening and confirming the presence of phospholipid-dependent LA autoantibodies. The screening protocol utilizes an activator reagent that contains a unique formulation of relipidated recombinant human tissue factor and calcium. The use of recombinant tissue factor in the formulation of the dPT test improves the test’s performance. In the confirmatory protocol, a uniquely formulated phospholipid reagent is used to demonstrate the phospholipid-dependent nature of the LA detected in samples that tested positive in the screening protocol.
Clotting is initiated by activating the extrinsic coagulation pathway with tissue factor in the presence of calcium ions. Tissue Factor binds to Factor VIIa resulting in the activation of Factor IX and Factor X. The subsequent conversion of prothrombin to thrombin by Factor Xa initiates clot formation by cleaving fibrinogen to fibrin. Activation of the tissue factor pathway bypasses the intrinsic (contact) pathway and excludes any interference from deficiencies of Factor XII. REF 824
SAMPLES | Citrate collected plasma |
SAMPLE PREPARATION | Neat |
SAMPLE VOLUME | 100 μL of plasma |
TOTAL ASSAY TIME | < 5 minutes |
NORMAL CLOT TIME | 33 – 43 seconds |
SENSITIVITY | 100% |
SPECIFICITY | 91% |
PRECISION | Intra-assay CV < 4% Inter-assay CV < 5% |
NUMBER OF TESTS | 240 tests (120 screen/120 confirm) |